Journal
EUROPACE
Volume 23, Issue 10, Pages 1612-1676Publisher
OXFORD UNIV PRESS
DOI: 10.1093/europace/euab065
Keywords
NOACs; DOACs; apixaban; dabigatran; edoxaban; rivaroxaban
Categories
Funding
- Bayer Pharma AG
- Bristol-Myers Squibb
- Pfizer Alliance
- DaiichiSankyo Europe GmbH